{
    "Trade/Device Name(s)": [
        "Access Cortisol",
        "DxC 500i Clinical Analyzer"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K242190",
    "Predicate Device Reference 510(k) Number(s)": [
        "K050202"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGR",
        "JJE"
    ],
    "Summary Letter Date": "January 24, 2025",
    "Summary Letter Received Date": "January 24, 2025",
    "Submission Date": "March 4, 2025",
    "Regulation Number(s)": [
        "21 CFR 862.1205",
        "21 CFR 862.2160"
    ],
    "Regulation Name(s)": [
        "Cortisol (Hydrocortisone and Hydroxycorticosterone) Test System",
        "Analyzer, Chemistry (Photometric, Discrete), For Clinical Use"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Cortisol",
        "Hydrocortisone",
        "Hydroxycorticosterone"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Access Immunoassay Systems",
        "DxC 500i Clinical Analyzer",
        "DxC 500 AU Clinical Chemistry Analyzer",
        "Access 2 Immunoassay System"
    ],
    "Method(s)/Technology(ies)": [
        "Paramagnetic particle chemiluminescent immunoassay",
        "Competitive binding immuno-enzymatic assay"
    ],
    "Methodologies": [
        "Chemiluminescent immunoassay",
        "Competitive binding immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Access Cortisol assay and DxC 500i Clinical Analyzer for quantitative measurement of cortisol in serum, plasma, and urine using chemiluminescent immunoassay technology.",
    "Indications for Use Summary": "Quantitative determination of cortisol in human serum, plasma (heparin, EDTA), and urine using the Access Immunoassay Systems to aid in the diagnosis and treatment of adrenal gland disorders.",
    "fda_folder": "Clinical Chemistry"
}